Valuation: Chongqing Jiheng Pharmaceutical Co., Ltd.

Market Cap 2.29B 344M 308M 284M 257M 480M 32.69B 489M 3.38B 1.36B 17.2B 1.29B 1.26B 54.24B P/E 2024
-2.74x
P/E 2025 -7.41x
Enterprise Value 2.7B 406M 364M 335M 303M 567M 38.57B 577M 3.99B 1.6B 20.29B 1.52B 1.49B 63.98B EV / Sales 2024
2.87x
EV / Sales 2025 3.89x
Free-Float
54.4%
Yield 2024 *
-
Yield 2025 -
10-28 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 CI
08-14 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
04-24 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Chongqing Sansheng Industrial Co.,Ltd. agreed to acquire an additional 11.94% stake in Chongqing Chunrui Pharmaceutical and Chemical Co., Ltd. from Hao Tingyan. CI
03-16 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/10/25 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
26/08/25 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
04/07/25 Zhang Yanning and Cen Yetao completed the acquisition of 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
02/07/25 Zhang Yanning and Cen Yetao agreed to acquire 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
02/07/25 Zhang Yanning and Cen Yetao agreed to acquire 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
25/04/25 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25/04/25 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25/04/25 Chongqing Sansheng Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt CI
1 day-1.76%
1 week-7.71%
Current month-19.47%
1 month-19.47%
3 months-4.29%
6 months-28.27%
Current year-25.88%
1 week 3.31
Extreme 3.31
3.64
1 month 3.31
Extreme 3.31
4.24
Current year 3.18
Extreme 3.18
6.24
1 year 3.18
Extreme 3.18
6.24
3 years 1.24
Extreme 1.24
6.24
5 years 1.24
Extreme 1.24
7.83
10 years 1.24
Extreme 1.24
31.05
Manager TitleAgeSince
Chief Executive Officer 59 01/03/2010
Director of Finance/CFO 52 21/04/2023
Chief Tech/Sci/R&D Officer 49 -
Director TitleAgeSince
Director/Board Member 54 27/09/2019
Director/Board Member 74 -
Director/Board Member 69 27/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.76%-7.71%-30.64%-4.56% 344M
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +1.38%+4.64%+38.87%+74.37% 426.23B
Weighted average by Cap. +1.19%+6.60%+50.87%+98.31%

Financials

2024 2025
Net sales 1.2B 180M 161M 148M 134M 251M 17.06B 255M 1.76B 708M 8.97B 674M 660M 28.3B 900M 135M 121M 111M 101M 189M 12.84B 192M 1.33B 533M 6.75B 507M 497M 21.3B
Net income -650M -97.68M -87.48M -80.47M -72.91M -136M -9.27B -139M -960M -385M -4.88B -367M -359M -15.39B -420M -63.06M -56.47M -51.95M -47.07M -87.98M -5.99B -89.63M -619M -249M -3.15B -237M -232M -9.93B
Net Debt 1.66B 250M 224M 206M 186M 348M 23.7B 355M 2.45B 984M 12.47B 937M 917M 39.32B 412M 61.84M 55.39M 50.95M 46.16M 86.29M 5.87B 87.9M 608M 244M 3.09B 232M 227M 9.74B
Projected Income Statement - Annual - Chongqing Jiheng Pharmaceutical Co., Ltd.
Logo Chongqing Jiheng Pharmaceutical Co., Ltd.
Chongqing Jiheng Pharmaceutical Co Ltd, formerly Chongqing Sansheng Industrial Co Ltd is a China-based company primarily engaged in building materials and chemical, and pharmaceutical manufacturing businesses. The Company operates two main businesses. The building materials and chemical business is primarily engaged in the production and sales of ready-mixed concrete, water-reducing agents, expanding agents and sulfuric acid. The pharmaceutical manufacturing business is primarily engaged in the production and sales of pharmaceutical intermediates such as procaine hydrochloride and cefoxitin intermediates, active pharmaceutical ingredients (APIs) such as acetaminophen and clopidogrel hydrochloride, and pharmaceutical preparations such as compound acetaminophen and diphenhydramine tablets, and clopidogrel hydrochloride tablets. The Company conducts its businesses in the domestic market and overseas markets.
Employees
979
Date Price Change Volume
30/10/26 CN¥3.350 -1.76% 18,021,501
29/10/26 CN¥3.410 -2.29% 11,443,300
28/10/26 CN¥3.490 +1.16% 12,611,800
27/10/26 CN¥3.450 -3.90% 13,538,000
26/10/26 CN¥3.590 -1.10% 12,420,100
  1. Stock Market
  2. Stocks
  3. 002742 Stock